Petlife Pharmaceuticals, Inc.
PTLF
$0.0001
$0.000.00%
| 02/28/2018 | 11/30/2017 | 08/31/2017 | 05/31/2017 | 02/28/2017 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | 17.90K | -- | -- |
| Gross Profit | -- | -- | -17.90K | -- | -- |
| SG&A Expenses | 182.70K | 193.30K | 1.45M | 572.00K | 1.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 182.70K | 193.30K | 1.46M | 572.00K | 1.25M |
| Operating Income | -182.70K | -193.30K | -1.46M | -572.00K | -1.25M |
| Income Before Tax | -427.10K | -466.70K | -2.00M | -815.00K | -1.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -427.10K | -466.70K | -2.00M | -815.00K | -1.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -427.10K | -466.70K | -2.00M | -815.00K | -1.32M |
| EBIT | -182.70K | -193.30K | -1.46M | -572.00K | -1.25M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 74.45M | 73.87M | 145.07M | 62.54M | 44.58M |
| Average Diluted Shares Outstanding | 74.45M | 73.87M | 145.07M | 62.54M | 44.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
